These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 29853653)

  • 1. Antibody-Based In Vivo PET Imaging Detects Amyloid-β Reduction in Alzheimer Transgenic Mice After BACE-1 Inhibition.
    Meier SR; Syvänen S; Hultqvist G; Fang XT; Roshanbin S; Lannfelt L; Neumann U; Sehlin D
    J Nucl Med; 2018 Dec; 59(12):1885-1891. PubMed ID: 29853653
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Meier SR; Sehlin D; Roshanbin S; Falk VL; Saito T; Saido TC; Neumann U; Rokka J; Eriksson J; Syvänen S
    J Nucl Med; 2022 Feb; 63(2):302-309. PubMed ID: 34088777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient clearance of Aβ protofibrils in AβPP-transgenic mice treated with a brain-penetrating bifunctional antibody.
    Syvänen S; Hultqvist G; Gustavsson T; Gumucio A; Laudon H; Söderberg L; Ingelsson M; Lannfelt L; Sehlin D
    Alzheimers Res Ther; 2018 May; 10(1):49. PubMed ID: 29793530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice.
    Neumann U; Rueeger H; Machauer R; Veenstra SJ; Lueoend RM; Tintelnot-Blomley M; Laue G; Beltz K; Vogg B; Schmid P; Frieauff W; Shimshek DR; Staufenbiel M; Jacobson LH
    Mol Neurodegener; 2015 Sep; 10():44. PubMed ID: 26336937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPECT imaging of distribution and retention of a brain-penetrating bispecific amyloid-β antibody in a mouse model of Alzheimer's disease.
    Gustavsson T; Syvänen S; O'Callaghan P; Sehlin D
    Transl Neurodegener; 2020 Sep; 9(1):37. PubMed ID: 32951598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody engagement with amyloid-beta does not inhibit [
    Xiong M; Dahlén A; Roshanbin S; Wik E; Aguilar X; Eriksson J; Sehlin D; Syvänen S
    J Neurochem; 2024 Sep; 168(9):2601-2610. PubMed ID: 38721627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High detection sensitivity with antibody-based PET radioligand for amyloid beta in brain.
    Fang XT; Hultqvist G; Meier SR; Antoni G; Sehlin D; Syvänen S
    Neuroimage; 2019 Jan; 184():881-888. PubMed ID: 30300753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Small-Animal PET Outcome Measures to Detect Disease Modification Induced by BACE Inhibition in a Transgenic Mouse Model of Alzheimer Disease.
    Deleye S; Waldron AM; Verhaeghe J; Bottelbergs A; Wyffels L; Van Broeck B; Langlois X; Schmidt M; Stroobants S; Staelens S
    J Nucl Med; 2017 Dec; 58(12):1977-1983. PubMed ID: 28611242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of immunotherapy with a brain penetrating Aβ antibody in a mouse model of Alzheimer's disease.
    Gustavsson T; Metzendorf NG; Wik E; Roshanbin S; Julku U; Chourlia A; Nilsson P; Andersson KG; Laudon H; Hultqvist G; Syvänen S; Sehlin D
    Alzheimers Res Ther; 2023 May; 15(1):90. PubMed ID: 37131196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The β-secretase (BACE) inhibitor NB-360 in preclinical models: From amyloid-β reduction to downstream disease-relevant effects.
    Neumann U; Machauer R; Shimshek DR
    Br J Pharmacol; 2019 Sep; 176(18):3435-3446. PubMed ID: 30657591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bispecific Tribody PET radioligand for visualization of amyloid-beta protofibrils - a new concept for neuroimaging.
    Syvänen S; Fang XT; Hultqvist G; Meier SR; Lannfelt L; Sehlin D
    Neuroimage; 2017 Mar; 148():55-63. PubMed ID: 28069541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer's Disease Mice.
    Rofo F; Meier SR; Metzendorf NG; Morrison JI; Petrovic A; Syvänen S; Sehlin D; Hultqvist G
    Neurotherapeutics; 2022 Sep; 19(5):1588-1602. PubMed ID: 35939261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered amyloid-β structure markedly reduces gliosis in the brain of mice harboring the Uppsala APP deletion.
    Pagnon de la Vega M; Syvänen S; Giedraitis V; Hooley M; Konstantinidis E; Meier SR; Rokka J; Eriksson J; Aguilar X; Spires-Jones TL; Lannfelt L; Nilsson LNG; Erlandsson A; Hultqvist G; Ingelsson M; Sehlin D
    Acta Neuropathol Commun; 2024 Feb; 12(1):22. PubMed ID: 38317196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of chronic BACE1 inhibition in PS2APP mice depends on the regional Aβ deposition rate and plaque burden at treatment initiation.
    Brendel M; Jaworska A; Overhoff F; Blume T; Probst F; Gildehaus FJ; Bartenstein P; Haass C; Bohrmann B; Herms J; Willem M; Rominger A
    Theranostics; 2018; 8(18):4957-4968. PubMed ID: 30429879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indium-111 radiolabelling of a brain-penetrant Aβ antibody for SPECT imaging.
    Gustavsson T; Herth MM; Sehlin D; Syvänen S
    Ups J Med Sci; 2024; 129():. PubMed ID: 38863725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
    Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
    J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease.
    Snellman A; López-Picón FR; Rokka J; Salmona M; Forloni G; Scheinin M; Solin O; Rinne JO; Haaparanta-Solin M
    J Nucl Med; 2013 Aug; 54(8):1434-41. PubMed ID: 23833271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined treatment with a BACE inhibitor and anti-Aβ antibody gantenerumab enhances amyloid reduction in APPLondon mice.
    Jacobsen H; Ozmen L; Caruso A; Narquizian R; Hilpert H; Jacobsen B; Terwel D; Tanghe A; Bohrmann B
    J Neurosci; 2014 Aug; 34(35):11621-30. PubMed ID: 25164658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Cyclooxygenase-1 in Activated Microglia During Amyloid Plaque Progression: PET Studies in Alzheimer's Disease Model Mice.
    Shukuri M; Mawatari A; Ohno M; Suzuki M; Doi H; Watanabe Y; Onoe H
    J Nucl Med; 2016 Feb; 57(2):291-6. PubMed ID: 26585055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [
    Nguyen GAH; Liang C; Mukherjee J
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.